JCV vaccination could reduce the risk of developing cognitive decline, dementia, strokes and brain tumours, by preventing chronic JCV cerebral infection, and recurrent reactivation.
Katona
Stephen
S
D001932:Brain Neoplasms / Q000517:prevention & control*; D002908:Chronic Disease; D003072:Cognition Disorders / Q000517:prevention & control*; D003704:Dementia / Q000517:prevention & control*; D018792:Encephalitis, Viral / Q000517:prevention & control*; D006801:Humans; D007577:JC Virus / Q000235:genetics / Q000276:immunology*; D016133:Polymerase Chain Reaction; D027601:Polyomavirus Infections / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D020521:Stroke / Q000517:prevention & control*; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology
D014765:Viral Vaccines